首页> 外文会议>World biomaterials congress >Investigation of drug/microRNA co-delivery system for simultaneously inhibiting both common cancer cells and cancer stem cells
【24h】

Investigation of drug/microRNA co-delivery system for simultaneously inhibiting both common cancer cells and cancer stem cells

机译:同时抑制普通癌细胞和癌干细胞的药物/ microRNA共递送系统的研究

获取原文

摘要

In the past decades, polymeric nano-drug delivery system has made great progress in the treatment of malignant tumor. However, the tumor faces recurrence and metastasis when stopping target drug or gene therapy, resulting in more serious complications. Recent study revealed that this phenomenon lies in the existence of a small group of specific cells in the cancer cells, called "cancer stem cells", which are highly tolerant of normal chemotherapy and genetherapy.Although specific microRNA can effectively inhibit the growth of cancer stem cells and metastasis. The solo treatment of cancer stem cells can't effective inhibit the proliferation of tumor, because there were a large number of common cancer cells existing in tumor tissues, and mature common cancer cells possibly mutated into cancer stem cells. This project plans to design a kind of reduction sensitivite cationic polymeric micelles. In the hydrophilic cationic outer shell, the micelles complex microRNAs via electrostatic interaction which can inhibit the growth and metastasis of cancer stem cells and promote cancer stem cells differentiation into common cancer cells; Meanwhile, in the hydrophobicity inner core, the micelles load adriamycin with efficient anti-proliferation effect to common tumor cells, in order to achieve the purpose of inhibiting both common cancer cells and cancer stem cells simultaneously, and enhancing anti-tumor therapeutic effect, preventing recurrence and metastasis of tumor. The results indicated the cationic polymeric micelles could stablily encapsulate the DOX, and complex microRNAs on the surfaces of micelles via electrostatic interaction. The nano-size of the both empty micelles and DOX-encapsulated micelles was range from 50 nm to 200 nm while narrow size distribution. The cytotoxicity experiments demonstrated that the PAA-g-PEG/PArg micelles have good biocompatibility as same as control sample, compared with Dox-incorporated PAA-g-PEG/PArg micelle group, the co-delivery of drug and gene PAA-g-PEG/PArg micelles groups were more efficiently internalized into MCF-7 cells, and enhance the ability of inhibitting cell proliferation by CLSM and flow cytometry test. In the MCF-7-bearing nude mouse models, the PAA-g-PEG/PArg micelles groups could efficiently accumulate in the tumor site by the fluorescence optical imaging technique, meanwhile, it demonstrated excellent solid tumor growth inhibition effect and the capacity for preventing recurrence and metastasis of tumor by investigating the tumor volume and body weight changes, as well as survive study of the tumor-bearing Balb/c mice. The PAA-g-PEG/PArg cationic polymeric micelles as a safe and high efficiency drug delivery system was expected to be a promising co-delivery carrier system that enables simultaneously targeting delivery hydrophobic chemotherapy drugs and negative charge of therapeutic siRNA molecules to tumor tissue and significantly enhanced antitumor effects. National Natural Science Foundation of China (Grant No. 21174090,51403138; and Young Teachers Science Foundation of Sichuan University (Grant No. 20HSCU11016)..
机译:在过去的几十年中,聚合物纳米药物递送系统在治疗恶性肿瘤方面取得了长足的进步。然而,当停止靶向药物或基因治疗时,肿瘤将面临复发和转移,导致更严重的并发症。最近的研究表明,这种现象在于癌细胞中有一小部分特异性细胞被称为“癌症干细胞”,它们对正常的化学疗法和基因疗法具有高度的耐受性。尽管特异性的microRNA可以有效地抑制癌症干细胞的生长。细胞和转移。肿瘤干细胞的单独治疗不能有效地抑制肿瘤的增殖,因为肿瘤组织中存在大量的普通癌细胞,而成熟的普通癌细胞可能会突变为癌症干细胞。该项目计划设计一种还原敏化阳离子聚合物胶束。在亲水性阳离子外壳中,胶束通过静电相互作用复合微小RNA,可以抑制癌细胞干细胞的生长和转移,促进癌细胞干细胞分化为普通癌细胞。同时,在疏水性内芯中,胶束对普通肿瘤细胞加载了具有有效抗增殖作用的阿霉素,以达到同时抑制普通癌细胞和癌干细胞并增强抗肿瘤治疗效果的目的。肿瘤的复发转移。结果表明,阳离子聚合物胶束可以通过静电相互作用稳定地包裹DOX和复杂的microRNA在胶束表面。空胶束和DOX封装的胶束的纳米尺寸在50 nm至200 nm范围内,而尺寸分布较窄。细胞毒性实验表明,与掺有Dox的PAA-g-PEG / PArg胶束组,药物和PAA-g-基因的共同递送相比,PAA-g-PEG / PArg胶束与对照样品具有良好的生物相容性。 PEG / PArg胶束组更有效地内化到MCF-7细胞中,并通过CLSM和流式细胞术测试增强了抑制细胞增殖的能力。在带有MCF-7的裸鼠模型中,PAA-g-PEG / PArg胶束基团可以通过荧光光学成像技术有效地聚集在肿瘤部位,同时具有出色的实体瘤生长抑制作用和预防能力。通过研究肿瘤的体积和体重的变化以及对荷瘤Balb / c小鼠的生存研究,研究肿瘤的复发和转移。 PAA-g-PEG / PArg阳离子聚合物胶束作为一种安全高效的药物递送系统,有望成为一种有前途的共递送载体系统,该系统能够同时靶向将疏水化学疗法药物和治疗性siRNA分子的负电荷靶向肿瘤组织和肿瘤。显着增强了抗肿瘤作用。国家自然科学基金(批准号21174090,51403138;四川大学青年教师科学基金会(批准号20HSCU11016)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号